Body mass index and breast cancer risk in Japan: A pooled analysis of eight population-based cohort studies

Annals of Oncology

Volumn 25, Issue 2, 2014, Pages 519-524

  Wada, K ^a   Nagata, C ^a   Tamakoshi, A ^b   Matsuo, K ^c   Oze, I ^d   Wakai, K ^e   Tsuji, I ^f   Sugawara, Y ^f   Mizoue, T ^g   Tanaka, K ^h   Iwasaki, M ⁱ   Inoue, M ^i,j   Tsugane, S ⁱ   Sasazuki, S ⁱ  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^h SAGA UNIVERSITY   (Japan)

ⁱ NATIONAL CANCER CENTER   (Japan)

^j UNIVERSITY OF TOKYO   (Japan)

more..

Author keywords

Body mass index; Breast cancer; Cohort study; Pooled analysis

Indexed keywords

ADULT; ARTICLE; BODY MASS; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; PREMENOPAUSE; PRIORITY JOURNAL; BREAST NEOPLASMS; COMPLICATION; INCIDENCE; JAPAN; META ANALYSIS; OVERWEIGHT; POSTMENOPAUSE; PROSPECTIVE STUDY; RISK FACTOR;

BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; JAPAN; OVERWEIGHT; POSTMENOPAUSE; PREMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84893377867     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt542     Document Type: Article

References (38)

1. Forouzanfar MH, Foreman KJ, Delossantos AM et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 2011; 378: 1461-1484.
2. Yang XR, Chang-Claude J, Goode EL et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 2011; 103: 250-263.
3. Parr CL, Batty GD, Lam TH et al. Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424,519 participants. Lancet Oncol 2010; 11: 741-752.
4. van den Brandt PA, Spiegelman D, Yaun SS et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000; 152: 514-527.
5. Cheraghi Z, Poorolajal J, Hashem T et al. Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis. PLoS One 2012; 7: e51446.
6. Suzuki R, Orsini N, Saji S et al. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status-a meta-analysis. Int J Cancer 2009; 124: 698-712.
7. Renehan AG, Tyson M, Egger M et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578.
8. Ursin G, Longnecker MP, Haile RW et al. A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 1995; 6: 137-141.
9. Suzuki S, Kojima M, Tokudome S et al. Obesity/weight gain and breast cancer risk: findings from the Japan collaborative cohort study for the evaluation of cancer risk. J Epidemiol 2013; 23: 139-145.
10. Iwasaki M, Otani T, Inoue M et al. Body size and risk for breast cancer in relation to estrogen and progesterone receptor status in Japan. Ann Epidemiol 2007; 17: 304-312.
11. Kuriyama S, Tsubono Y, Hozawa A et al. Obesity and risk of cancer in Japan. Int J Cancer 2005; 113: 148-157.
12. Kawai M, Minami Y, Kuriyama S et al. Adiposity, adult weight change and breast cancer risk in postmenopausal Japanese women: the Miyagi Cohort Study. Br J Cancer 2010; 103: 1443-1447.
13. Key TJ, Sharp GB, Appleby PN et al. Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br J Cancer 1999; 81: 1248-1256.
14. Goodman MT, Cologne JB, Moriwaki H et al. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors. Prev Med 1997; 26: 144-153.
15. Wu MH, Chou YC, Yu JC et al. Hormonal and body-size factors in relation to breast cancer risk: a prospective study of 11,889 women in a low-incidence area. Ann Epidemiol 2006; 16: 223-229.
16. Hirose K, Takezaki T, Hamajima N et al. Dietary factors protective against breast cancer in Japanese premenopausal and postmenopausal women. Int J Cancer 2003; 107: 276-282.
17. Hu YH, Nagata C, Shimizu H et al. Association of body mass index, physical activity, and reproductive histories with breast cancer: a case-control study in Gifu, Japan. Breast Cancer Res Treat 1997; 43: 65-72.
18. Kato I, Miura S, Kasumi F et al. A case-control study of breast cancer among Japanese women: with special reference to family history and reproductive and dietary factors. Breast Cancer Res Treat 1992; 24: 51-59.
19. Shin A, Matthews CE, Shu XO et al. Joint effects of body size, energy intake, and physical activity on breast cancer risk. Breast Cancer Res Treat 2009; 113: 153-161.
20. Ahn J, Schatzkin A, Lacey JV, Jr et al. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med 2007; 167: 2091-2102.
21. Reeves GK, Pirie K, Beral V et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007; 335: 1134.
22. Lahmann PH, Hoffmann K, Allen N et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2004; 111: 762-771.
23. Sonnenschein E, Toniolo P, Terry MB et al. Body fat distribution and obesity in preand postmenopausal breast cancer. Int J Epidemiol 1999; 28: 1026-1031.
24. Kotsopoulos J, Chen WY, Gates MA et al. Risk factors for ductal and lobular breast cancer: results from the nurses' health study. Breast Cancer Res 2010; 12: R106.
25. Michels KB, Terry KL, Willett WC. Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med 2006; 166: 2395-2402.
26. Suzuki R, Rylander-Rudqvist T, Ye W et al. Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: a prospective cohort study. Int J Cancer 2006; 119: 1683-1689.
27. Tehard B, Lahmann PH, Riboli E et al. Anthropometry, breast cancer and menopausal status: use of repeated measurements over 10 years of follow-upresults of the French E3N women's cohort study. Int J Cancer 2004; 111: 264-269.
28. Vatten LJ, Kvinnsland S. Body mass index and risk of breast cancer. A prospective study of 23,826 Norwegian women. Int J Cancer 1990; 45: 440-444.
29. Galanis DJ, Kolonel LN, Lee J et al. Anthropometric predictors of breast cancer incidence and survival in a multi-ethnic cohort of female residents of Hawaii, United States. Cancer Causes Control 1998; 9: 217-224.
30. Smith-Warner SA, Spiegelman D, Yaun SS et al. Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA 1998; 279: 535-540.
31. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
32. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
33. Tworoger SS, Eliassen AH, Missmer SA et al. Birthweight and body size throughout life in relation to sex hormones and prolactin concentrations in premenopausal women. Cancer Epidemiol Biomarkers Prev 2006; 15: 2494-2501.
34. Nagata C, Shimizu H, Takami R et al. Dietary soy and fats in relation to serum insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 levels in premenopausal Japanese women. Nutr Cancer 2003; 45: 185-189.
35. Nagata C, Wada K, Nakamura K et al. Associations of body size and reproductive factors with circulating levels of sex hormones and prolactin in premenopausal Japanese women. Cancer Causes Control 2011; 22: 581-588.
36. Lawlor DA, Smith GD, Ebrahim S. Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women's Heart and Health Study. Cancer Causes Control 2004; 15: 267-275.
37. Pichard C, Plu-Bureau G, Neves ECM et al. Insulin resistance, obesity and breast cancer risk. Maturitas 2008; 60: 19-30.
38. Renehan AG, Zwahlen M, Minder C et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004; 363: 1346-1353.